According to reports, the axe is coming down all over the pharma world on research and development projects that are not yielding immediate results. AstraZeneca(Atacand, Crestor), GlaxoSmithKline (Advair, Boniva) and Pfizer (Benadryl, Lipitor) have all already begun to scrap projects, while others like Sanofi-Aventis (Allegra, Plavix) are about to pick up the trend and start [...]
Entries Tagged as 'Sanofi-Aventis'
Big Pharma making big cuts in R&D
February 8th, 2010 · 1 Comment
Tags: AstraZeneca · Big Pharma · GlaxoSmithKline · Pfizer · Pharmaceutical companies · Prescription drugs · Sanofi-Aventis
The Fosamax mistrial, and other options in osteoporosis medication
September 25th, 2009 · 1 Comment
Earlier this month, a closely-watched trial over the osteoporosis drug Fosamax ended in mistrial, to the frustration of nearly everyone involved. The trial was marked by great tension, with a deadlocked jury, reports of threats of physical violence, and a judge-ordered cooling-down period. What could cause such intense drama? Well, this was just one of [...]
Tags: Boniva · Drug safety · Eli Lilly · Fosamax · GlaxoSmithKline · Medical information · Merck · Prescription drugs · Roche · Sanofi-Aventis
Zimulti: An obesity drug to die for?
June 17th, 2007 · No Comments
From Bloomberg: Sanofi-Aventis SA shares had their biggest drop in three years, wiping out more than $7 billion in market value, after a U.S. panel blocked the company’s new weight-loss pill because it was linked to suicides. Says Derek Lowe: Everyone will have heard the news about Wednesday’s FDA Advisory Commitee vote on Accomplia / [...]
Tags: FDA · Pharmaceutical companies · Prescription drugs · Sanofi-Aventis · Zimulti
Generic Ambien on the way
April 30th, 2007 · 1 Comment
In case you were sleeping when the news was announced last week, generic versions of Ambien are on the way. As Reuters reported: The Food and Drug Administration said … that regulators had approved generic versions of Ambien, a blockbuster sleeping pill from Sanofi-Aventis. The drug, also known as zolpidem tartrate, has been linked to [...]
Tags: Ambien · Sanofi-Aventis
New “black box” warning on controversial antibiotic
February 14th, 2007 · No Comments
The FDA announced that the antibiotic Ketek, used to treat pneumonia, must come with a new “black box label” — the strongest warning the agency can impose on a drug. Additionally, Ketek can no longer be recommended for treating milder conditions such as sinusitis and bronchitis. The changes come after the medication was found to [...]
[Read more →]
Tags: Ketek · Prescription drugs · Sanofi-Aventis